NW

Nicole Weerden

Chief Operating Officer

Arovella Therapeutics ASX: ALA

Melbourne, Victoria


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Arovella Therapeutics ASX: ALA
Industry
research
Employees
19.0
Seniority
C suite
Annual Revenue
268000.0

Professional Summary

Nicole Weerden serves as Chief Operating Officer at Arovella Therapeutics ASX: ALA. Arovella Therapeutics ASX: ALA operates in the research sector with approximately 19.0 employees. The company is headquartered in Melbourne, Victoria. Arovella Therapeutics ASX: ALA generates annual revenue of 268000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 2 executives at Arovella Therapeutics ASX: ALA.
  • 2,608 executive contacts are available in Victoria.
  • Our database includes 201,469 c suite-level executives.

Technologies

Outlook Mobile Friendly Vimeo Google Tag Manager WordPress.org YouTube Squarespace ECommerce Basis

Keywords

biotechnology advanced cell therapy oncology inkt cell therapy invariant natural killer t cell therapy platform car engineering blood cancers solid tumours biotechnology research inkt cells car-inkt therapy cd19 targeting solid tumour treatment blood cancer therapy allogeneic cell therapy off-the-shelf car therapy cldn18.2 targeting cytokine technology il-12-tm tumour microenvironment immune cell therapy chimeric antigen receptor cancer immunotherapy multi-targeting therapy tumour angiogenesis immune system modulation personalized medicine cellular therapeutics therapeutic development pharmaceutical innovation cancer treatment haematological cancer cancer vaccines cell engineering preclinical studies antigen recognition tumour-associated antigens cancer cell destruction adaptive immune response vector technology drug development clinical trials patient-centric approach biopharmaceuticals cancer research therapeutic platforms cytokine release syndrome t cell activation tumour immunity cd1d recognition nkg2d pathway cancer strategies pro-tumour cells monoclonal antibody development patient access healthcare innovation hospital & health care health care health wellness & fitness

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Nicole Weerden?

Nicole Weerden's verified email address is available on MessageCEO. They currently work at Arovella Therapeutics ASX: ALA. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Nicole Weerden lead?

Nicole Weerden is Chief Operating Officer at Arovella Therapeutics ASX: ALA, a company in the research sector with 19.0 employees. The company is based in Melbourne, Victoria.

What industry is Nicole Weerden in?

Nicole Weerden works in the research industry as Chief Operating Officer at Arovella Therapeutics ASX: ALA. MessageCEO provides verified contact information for executives across all major industries.

Is Nicole Weerden's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Nicole Weerden's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 11, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans